CADTH Collaborative Workspaces Registration

( Last Updated : December 21, 2017)

To submit and contribute drug or therapy review information, input, and/or feedback online, you must be registered for one of the following CADTH Optimal Use CAR T-Cell Therapy Reviews or CADTH Pharmaceutical Reviews Programs —– the CADTH Common Drug Review (CDR) or the CADTH pan-Canadian Oncology Drug Review (pCODR).

You may be eligible to register if you are a:

  • member of a pCODR or CAR T-cell patient group
  • clinician
  • member of a tumour group
  • drug manufacturer or designated consultant

For more information on registration, please see the CDR, pCODR or CAR T-cell registration requirements.

How to Register for CADTH Collaborative Workspaces

Note: It is important to have your registration completed in advance of CADTH Reviews deadlines for submitting information, input, and/or feedback.

Step 1 Review and confirm that you meet the CDRpCODR or CAR T-cell registration criteria.

Step 2

  • Complete and submit a registration form for the CDR, pCODR. or CAR T-cell. Multiple registrants per group are allowed.

  • If you already have an account and require access to submit to another drug or therapy program please complete the Request Additional Program Access Form. The information submitted will be reviewed and verified by CADTH.

Step 3

Within two business days of submitting your registration request, you will receive an email from CADTH with instructions on the final steps for completing your registration.

Step 4

Complete the steps outlined in the email. Your email address will be your username and you will also be required to create a password. These credentials will then allow you to log in to CADTH's secure Collaborative Workspaces.

When you log in as a user, you will be automatically directed to one of four pages based on your profile: manufacturer, tumour group, patient group, or clinician.

If you have any questions about the registration process, please send us an email at